16373-02-7

Basic information

• Product Name: Benzenemethanol, 3,5-bis(1,1-dimethylethyl)-2-hydroxy-
• Synonyms: 3,5-(1,1-dimethylethyl)-2-hydroxy-benzenemethanol;2,6-di-tert-butyl-4-hydroxymethylphenol;2,4-di-tert-butyl-6-hydroxymethylphenol;2,4-di-t-butyl-6-hydroxymethylphenol;3,5-di-tert-butyl-2-hydroxybenzyl alcohol;CCG-5066;2,4-tert-butyl-6-hydroxym ethyl-phenol;(2-hydroxy-3,5-di-tert-butyl)benzyl alcohol
• CAS NO: 16373-02-7
• Molecular Formula: C15H24O2
• Molecular Weight: 236.354
• Mol File: 16373-02-7.mol
• Article Data: 32

Chemical Properties

• Melting Point: 98-99 °C
• Boiling Point: 118-125 °C(Press: 0.7 Torr)
• Density: 1.005±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzenemethanol, 3,5-bis(1,1-dimethylethyl)-2-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanol, 3,5-bis(1,1-dimethylethyl)-2-hydroxy-(16373-02-7)
• EPA Substance Registry System: Benzenemethanol, 3,5-bis(1,1-dimethylethyl)-2-hydroxy-(16373-02-7)

Safety Data

• Hazardous Substances Data: 16373-02-7(Hazardous Substances Data)

Upstream product

• 50-00-0 formaldehyd 
• 96-76-4 2,4-di-tert-Butylphenol 
• 39117-89-0 5,7-di-t-butyl-1-oxaspiro<2.5>octa-5,7-dien-4-one 
• 19715-19-6 3,5-ditertbutyl salicylic acid 
• 98-54-4 para-tert-butylphenol 
• 120695-69-4 6,8-di-tert-butyl-3-(3,5-di-tert-butyl-2-hydroxybenzyl)-2H-3,4-dihydrobenz-1,3-oxazine 
• 37942-07-7 3,5-di-tert-butyl-2-hydroxybenzaldehyde 
• 660390-74-9 1-[5-(6,8-di-tert-butyl-2-oxo-4H-2λ⁵-benzo[1,3,2]dioxaphosphinin-2-yloxymethyl)-2,5-dihydro-furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 7664-93-9 sulfuric acid 

Downstream Products

• 14362-12-0 2,2'-methylenebis(4,6-di-tert-butylphenol) 
• 616-55-7 2,4-di-tert-butyl-6-methylphenol 
• 37758-52-4 6,6'-(ethane-1,2-diyl)bis(2,4-di-tert-butylphenol) 
• 24785-45-3 2,4-di-tert-butyl-6-[(n-dodecylthio)methyl]phenol 
• 1246811-33-5 2,4-di-tert-butyl-6-[(cyclohexylthio)methyl]phenol 

Relevant articles and documents

An improved method for synthesis of Jacobsen's catalyst

The improved synthesis of Jacobsen catalyst 1 was developed. For both enantiomers the obtained overall yield starting from commercially available 4 was 80-85%.

3,5-Di-(tert-Butyl)-6-fluoro-cycloSal-d4TMP - A Pronucleotide with a Considerably Improved Masking Group

A new, considerably improved cycloSal masking group has been developed. This new group combines four desirable properties and has been attached to the anti-HIV drug 2′,3′-dideoxy-2′,3′-didehydrothymidine (d4T, 1) to give 3,5-(di-tert-butyl)-6-fluoro-cycloSal-d4TMP (2i). This phosphate triester has a reasonable chemical half-life, highly selectively released d4TMP, has poor - if any - inhibitory effect on butyrylcholinesterase (BChE), and achieved the TK-bypass. ( Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003).

PNO ligand containing planar chiral ferrocene and application thereof

The invention discloses a PNO ligand containing planar chiral ferrocene and application thereof. The PNO ligand containing planar chiral ferrocene is a planar chiral ferrocene-containing and phenol-containing PNO ligand as shown in a general formula (I) or (II) which is described in the specification, or a planar chiral ferrocene-containing and aryl-phosphoric-acid-containingPNO ligand containing as shown in a general formula (III) or (IV) which is described in the specification, or a planar chiral ferrocene-containing and carbon-chiral-phenol-containingPNO ligand as shown in a general formula (V) or (VI) which is described in the specification. The invention provides tridentate PNO ligands and processes for their complexation with transition metal salts or transition metal complexes; the introduction of salicylaldehyde and derivatives thereof, which are simple and easy to obtain, enables the ligands to have a bifunctionalization effect, and -OH in a formed catalyst has stronger acidity and is beneficial to combination with N/O in polar double bonds. Therefore, due to the bifunctionalization effect of the catalyst, the interaction between the catalyst and a substrate can be greatly improved, so a reaction can obtain higher catalytic activity and stereoselectivity.

A kind Salen - Fe complex and its preparation method and application

The invention relates to a Salen-Fe-like complex, and a preparation method and application thereof. The structure of the complex is disclosed in the specification. The preparation method comprises the following steps: carrying out a two-step process on cy